Breast cancer often relapses in distant organs even when complete regression of primary tumors is achieved after initial ...

Federal budget cuts to the National Institutes of Health and others are affecting graduate students at Cold Spring Harbor Lab ...

Each time a cell divides, a small section of each chromosome's protective cap—the telomere—is worn away. Most cells use an ...

The study, published Tuesday in The Lancet Oncology, focused on women under 55 with and without a uterus. CBS News medical ...

A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...

Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...

Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood cancer multiple myeloma.

Panelists discuss the rapidly evolving endocrine treatment landscape in oncology, emphasizing the shift toward personalized ...

Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...

UNC is leading a large study seeking new ways to treat breast cancer.

South Dakota's All Women Count program provides early detection cancer screenings for over 1,500 low-income women.

Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, ...